ADT1417-Mupadolimab Biosimilar-(NT5E / CD73)-Research Biosimilar Antibody
- +1 609-736-0910
- info@alphalifetech.com
- 90 State Street, STE 700 Office 40, Albany, NY 12207 United States
Product Background
Catalog Number |
ADT1417 |
Product Name |
ADT1417-Mupadolimab Biosimilar-(NT5E / CD73)-Research Biosimilar Antibody |
Clonity |
Monoclonal |
|
Alternate Names anti-mouse NT5E antibody, anti-NT5E antibody, anti NT5E antibody, recombinant NT5E , NT5E antibody, anti-NT5E monoclonal antibody, NT5E antibodies, NT5E recombinant antibody, NT5E blocking antibody, CD73 recombinant antibody, CD73 blocking antibody |
|
Host |
CHO Cells |
Species |
Mouse |
Target |
NT5E/CD73 |
Gene ID |
4907 |
Isotype |
IgG1 Kappa |
Size |
100ug, 1mg, 5mg |
Research Area |
Cancer |
CAS Number |
2451856-97-4 |
Product Description |
Anti-NT5E / CD73 Reference Antibody (mupadolimab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is kappa. It has a predicted MW of 145.5 kDa. |
Molecular Weight |
145.5 KDa |
Application |
ELISA, Flow Cytometry, Kinetics (BLI), Kinetics (SPR), Functional assay |
Purity |
>95% as determined by SDS-PAGE |
Concentration |
batch dependent |
Buffer |
Supplied in PBS, PH6 |
Storage |
Store at -20 °C for 12 months. Store at -80 °C for long term storage. |
Shipping Condition |
Shipped on ice packs. |
Note |
This product is for research use only. |
Reference |
1. Huang, C. C., et al. (2015). “CD73: A novel target for cancer immunotherapy.” Frontiers in Immunology, 6, 1-10. DOI: 10.3389/fimmu.2015.00001.
2. Borsellino, G., et al. (2007). “CD73: A key player in the regulation of immune responses.” Nature Reviews Immunology, 7(8), 1-12. DOI: 10.1038/nri2150.
3. Bates, D. O., et al. (2013). “The role of CD73 in the regulation of immune responses.” Nature Reviews Immunology, 13(12), 1-12. DOI: 10.1038/nri3600.
|